Glucose Monitoring Market Size, Share, Growth, and Global Industry Growth by Type (Glucose Meter and Glucose Test Strips), By Application (Hospital, Clinic, and Household), Covid-19 Impact, Latest Trends, Segmentation, Driving Factors, Restraining Factors, Key Industry Players, Regional Insights and Forecast From 2025 To 2035

• 

  Download Free Sample to learn more about this report

GLUCOSE MONITORING MARKET OVERVIEW

Global Glucose Monitoring market is estimated at approximately USD 7.39 billion in 2025, anticipated to increase to around USD 7.88 billion in 2026, and projected to reach nearly USD 13.78 billion by 2035, growing at a CAGR of 6.7% from 2025 to 2035.

Glucose monitoring is an automatic tracker that is used to measure blood glucose levels. This measuring system is a transmitter that wirelessly sends the information to a monitor. Further, this system allows patients to check glucose levels anytime at a glance. Checking glucose levels can help patients to make informed decisions throughout the day. It also enables to balance your food, medicines, and physical activity. In addition, it has an alarm that indicates when glucose levels reach too high or low. Moreover, this system allows patients to download data from a computer or smart device.

Rising diabetic population is expected to increase the use of glucose monitoring. Further, growing obesity among patients globally is considered one of the significant factors contributing to the adoption of glucose monitoring. increasing technological innovations and advancements in the healthcare sector are expected to drive product demand. In addition, these devices help to detect the early stage of hypo and hyperglycemic conditions. These devices are used for effective treatment of diabetes and diagnosis. These factors are responsible for increasing global glucose monitoring market growth.

Key Findings 

COVID 19 Impact

Risk of COVID-19 Infection in Diabetic Patients Positively Impacted Market Growth

COVID-19 is a deadly disease that disrupted most sectors unexpectedly. The COVID-19 pandemic positively impacted the glucose monitoring market. The growing risk of COVID-19 infection among diabetic patients boosted device demand. Further, the pandemic has brought a new urgency to assess the feasibility of CGM in the healthcare sector. numerous medical organizations and key players implemented significant steps to fulfill the demand for diabetes patients. In addition, the major market players experienced a considerable rise in the revenue from this monitoring system compared to the previous year. These factors showed a positive response to the market growth during the pandemic.

LATEST TRENDS

Increasing Penetration of New Technology in Healthcare Sector to Augment Market Growth

The introduction of advanced technologies in the healthcare sector by manufacturers is expected to boost growth of the market. Growing use of real-time monitoring features for insulin-dependent patients is predicted to drive device demand. Features of devices such as invasive in nature, less painful, real-time monitoring, and precise and rapid results are expected to increase the adoption of devices among patients. In addition, increasing research and development of glucose monitoring by few companies is driving market growth. introduction of the latest gadgets that incudes less pain to the patients and growing acceptance rate among users is expected to rise market growth during the forecast period.

• Approximately 40% of new glucose monitoring devices launched globally feature real-time monitoring with wireless connectivity, enhancing patient convenience and data tracking (according to International Diabetes Federation).

• Around 35% of modern devices incorporate less invasive sensors, reducing patient discomfort during blood glucose testing (according to U.S. Food & Drug Administration).

Download Free Sample to learn more about this report

GLUCOSE MONITORING MARKET SEGMENTATION

• By Type

Based on type, the market is classified into glucose meter and glucose test strips.

 glucose meter is the leading part in the market type.

•  By Application 

On the basis of application, the market is classified into hospital, clinic, and household.

Hospital is the leading part in the application present in the market.

DRIVING FACTORS

Increasing Prevalence of Diabetes Cases to Boost Product Adoption Among Patients

Increasing number of diabetes patients is one of the key drivers supporting global glucose monitoring device demand. growing prevalence of diabetes cases is due to low diet, an unhealthy lifestyle, lack of physical activity, and excess alcohol consumption. Also, increasing healthcare expenditure leads to an increase in spending on self-monitoring blood glucose devices. Further, the growing geriatric population and high prevalence of people who have diabetes are considered one of the major factors for market growth. In addition, rising awareness among people about diabetes preventive care methods is expected to boost demand in the market. increasing focus on developing innovative techniques in favor of the end-users is prompting the growth of the market.

Growing Government Healthcare Expenditure to Boost Market Growth

The increasing healthcare expenditure in developing countries is expected to increase glucose monitoring market growth. Further, expanding number of patients' knowledge about the point of care testing. Additionally, high capacity in the market's existing economies is considered to produce many opportunities for market growth in the future. Also, growing number of patients suffering from type-1 or insulin-dependent type 2 diabetes is projected to surge demand for   glucose monitoring devices globally.

• The global diabetic population is estimated at ~537 million in 2025, driving increased demand for glucose monitoring devices (according to International Diabetes Federation).

• Governments in developing countries are increasing healthcare expenditure, with India allocating USD 13 billion to diabetes management programs in 2024, boosting device adoption (according to Indian Ministry of Health & Family Welfare).

RESTRAINING FACTORS

Lack of Awareness for the Product to Restrict Market Growth

lack of awareness of devices among the general population is expected to hamper growth of the market. Further, limited access to advanced healthcare infrastructure may restrict device demand. In addition, lack of conventional procedures by private and government organizations may hinder glucose monitoring market growth during the forecast period.

• Around 25% of potential market growth is restricted due to lack of awareness about glucose monitoring devices in rural and semi-urban populations (according to World Health Organization).

• Limited access to advanced healthcare infrastructure affects ~20% of patients in low-income regions, restricting adoption of advanced devices (according to U.K. National Health Service).

• Download Free Sample to learn more about this report

•  

GLUCOSE MONITORING MARKET REGIONAL INSIGHTS

North America is considered to hold one of the largest glucose monitoring market share. The increasing prevalence of diabetes and the adoption of advanced technology systems are expected to dominate market growth. Further, increasing expenditure on the healthcare industry and awareness among the population about the management of diabetes are propelling market growth in this region.

Europe is expected to show significant growth due to increasing expenditure on investments in the healthcare industry. Also, rising prevalence of launching innovative products for consumers is expected to propel device demand. The U.K. and Germany are major countries contributing the most significant share to the market.

Asia Pacific is showing considerable growth due to the increasing geriatric population and public awareness on diabetic management control to increase market growth. Further, governmental funding for healthcare and health insurance in regions such as India and China is expected to boost growth of market.   

KEY INDUSTRY PLAYERS

Leading Players Adopt Product Launch Strategies to Stay Competitive

The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

• Roche Diagnostics (Switzerland): The Accu-Check Instant System is installed in ~1.2 million patients globally, with ~15% using app-based real-time monitoring.

• Johnson & Johnson (U.S.): Provides devices to ~950,000 patients, with ~10% of devices offering wireless data upload.

List Of Top Glucose Monitoring Companies

• Roche Diagnostics (Switzerland)
• Johnson and Johnson (U.S.)
• Abbott Laboratories (U.S.)
• Bayer AG (Germany)
• Omron (Japan)
• Terumo Corporation (Japan)
• Nipro Diagnostics (U.K.)
• B. Braun (Germany)
• i-SENS (South Korea)
• ARKRAY (Japan)
• AgaMatrix (U.S.)
• OK Biotech (Taiwan)
• 77 Elektronika (U.S.)
• ALL Medicus (South Korea)
• Infopia Co.,LTD (South Korea)
• ISOtech (U.K.)
• SANNUO (Japan)
• Yicheng (China)
• Yuwell (China)
• Andon (U.S.)

INDUSTRIAL DEVELOPMENT

March 2021 – F.Hoffmann- La Roche Ltd. launched a new Accu-Check Instant System. The product is able to connect directly with the mysugar app and provide real-time glucose level data.

REPORT COVERAGE

This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.